Associate Professor Clare Scott is a clinician scientist, leading the Ovarian and Other Rare Gynaecological Cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs laboratory at WEHI and working as a medical oncologista doctor who specialises in the study, diagnosis and treatment of cancer at the Peter MacCallum Cancer Centre, Royal Women’s and Royal Melbourne Hospitals. Her clinical expertise is in gynaecological cancers and coordinating care for patients with rare cancers. I have 25 years’ experience in clinical cancer genetics, working in Familial Cancer Clinics.
Professor Clare Scott’s laboratory focuses on making pre-clinical models in which to study drug resistance in rare gynaecological cancers. She set up the national WEHI Stafford Fox Rare Cancer Program in order to facilitate the study of many rare cancer types which are poorly researched. She also set up the Australian Rare Cancer Portal so that expert rare cancer care and research could be streamlined for individuals, no matter where they live.
Claire believe’s that involving the community in research enhances the purpose of our research and magnifies the benefits of what we do.She also leads an ovarian cancer laboratory focused on developing targeted therapies for ovarian cancer with the aim to change the current treatment paradigm of “one size fits all” for women with ovarian cancer. This involves the use of novel pre-clinical models of epithelial ovarian cancer, complementing activities as a medical oncologista doctor who specialises in the study, diagnosis and treatment of cancer in breast and ovarian cancer.
Claire believes that focus on designing novel treatments targeted to specific molecules that are altered in epithelial ovarian cancer, with an emphasis on unraveling causes of drug resistance.
Location
The Royal Melbourne Hospital - Royal Park, Poplar Road, Parkville VIC, Australia
